4//SEC Filing
Sorensen Mel 4
Accession 0000905148-25-004171
CIK 0001563577other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:42 PM ET
Size
4.8 KB
Accession
0000905148-25-004171
Insider Transaction Report
Form 4
Sorensen Mel
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-11-20$0.02/sh−70,000$1,407→ 195,029 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.02 to $0.0201, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001444783
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:42 PM ET
- Size
- 4.8 KB